<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/rss+xml" href="https://feeds.transistor.fm/bench-strength" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>Bench Strength</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/bench-strength</itunes:new-feed-url>
    <description>Bench Strength is a podcast celebrating the incredible bench of AAV experts shaping the future of the field. In every episode, our host David Dismuke goes beyond the science to hear their story, deep perspectives, and vision for what comes next.</description>
    <copyright>© 2026 Forge Biologics</copyright>
    <podcast:guid>dde30928-6971-57f9-917c-5df1dff753ee</podcast:guid>
    <podcast:locked>yes</podcast:locked>
    <podcast:trailer pubdate="Tue, 11 Aug 2026 10:45:02 -0400" url="https://media.transistor.fm/b65fee0d/2b1fc331.mp3" length="1038352" type="audio/mpeg">Welcome to the Bench</podcast:trailer>
    <language>en</language>
    <pubDate>Wed, 12 Aug 2026 23:10:49 -0400</pubDate>
    <lastBuildDate>Wed, 12 Aug 2026 23:11:15 -0400</lastBuildDate>
    <link>https://www.forgebiologics.com/</link>
    <image>
      <url>https://img.transistorcdn.com/n9rCrbSI2ZEr5qbtfvqT8aPy9Zv9SxNe-IWirOE5-NI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wYjRm/MjM1ZTQyNjZlZWVk/MDA3N2Q2OWY1YzVh/ODFjNS5wbmc.jpg</url>
      <title>Bench Strength</title>
      <link>https://www.forgebiologics.com/</link>
    </image>
    <itunes:category text="Science">
      <itunes:category text="Life Sciences"/>
    </itunes:category>
    <itunes:category text="Business">
      <itunes:category text="Careers"/>
    </itunes:category>
    <itunes:type>episodic</itunes:type>
    <itunes:author>Forge Biologics</itunes:author>
    <itunes:image href="https://img.transistorcdn.com/n9rCrbSI2ZEr5qbtfvqT8aPy9Zv9SxNe-IWirOE5-NI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wYjRm/MjM1ZTQyNjZlZWVk/MDA3N2Q2OWY1YzVh/ODFjNS5wbmc.jpg"/>
    <itunes:summary>Bench Strength is a podcast celebrating the incredible bench of AAV experts shaping the future of the field. In every episode, our host David Dismuke goes beyond the science to hear their story, deep perspectives, and vision for what comes next.</itunes:summary>
    <itunes:subtitle>Bench Strength is a podcast celebrating the incredible bench of AAV experts shaping the future of the field.</itunes:subtitle>
    <itunes:keywords></itunes:keywords>
    <itunes:owner>
      <itunes:name>Forge Biologics</itunes:name>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>Maritza McIntyre - The Approval Playbook</title>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>Maritza McIntyre - The Approval Playbook</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d4e835d7-90de-464c-ba40-f0f6aff44c24</guid>
      <link>https://share.transistor.fm/s/3559ecdc</link>
      <description>
        <![CDATA[<p>Episode One: The Approval Playbook</p><p>Welcome to the first episode of the Bench Strength podcast, featuring Maritza McIntyre in conversation with Dr. David Dismuke.</p><p>In “The Approval Playbook,” Maritza and David dive into the world of regulatory affairs, FDA approval, gene therapy, and therapeutic development. Drawing from their career experiences in biotech, they explore how regulatory strategy has evolved, what it takes to successfully navigate the path to approval, and what the future holds for therapeutic pipelines.</p><p>Maritza shares her unique perspective on the FDA, drug development, regulatory strategy, and the evolving biopharmaceutical industry, offering insights into lessons from the past and the challenges and opportunities shaping the next generation of therapies.</p><p>Bench Strength is a podcast created by Forge Biologics. Hosted by CTO David Dismuke. Each episode features a new guest from across the gene therapy ecosystem. Everyone from scientists, clinicians, engineers, and innovators join to discuss what they're building, the lessons they've learned, and where the field is headed next. Whether you're developing your first program or preparing for commercialization, Bench Strength offers fresh perspectives from the people shaping the future of gene therapy.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Episode One: The Approval Playbook</p><p>Welcome to the first episode of the Bench Strength podcast, featuring Maritza McIntyre in conversation with Dr. David Dismuke.</p><p>In “The Approval Playbook,” Maritza and David dive into the world of regulatory affairs, FDA approval, gene therapy, and therapeutic development. Drawing from their career experiences in biotech, they explore how regulatory strategy has evolved, what it takes to successfully navigate the path to approval, and what the future holds for therapeutic pipelines.</p><p>Maritza shares her unique perspective on the FDA, drug development, regulatory strategy, and the evolving biopharmaceutical industry, offering insights into lessons from the past and the challenges and opportunities shaping the next generation of therapies.</p><p>Bench Strength is a podcast created by Forge Biologics. Hosted by CTO David Dismuke. Each episode features a new guest from across the gene therapy ecosystem. Everyone from scientists, clinicians, engineers, and innovators join to discuss what they're building, the lessons they've learned, and where the field is headed next. Whether you're developing your first program or preparing for commercialization, Bench Strength offers fresh perspectives from the people shaping the future of gene therapy.</p>]]>
      </content:encoded>
      <pubDate>Wed, 12 Aug 2026 23:10:49 -0400</pubDate>
      <author>Forge Biologics</author>
      <enclosure url="https://media.transistor.fm/3559ecdc/5ed0db6e.mp3" length="33314434" type="audio/mpeg"/>
      <itunes:author>Forge Biologics</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/NE3F6KwPXYmGZoo2W74NurItPM2ZZo0Vu2qxPffKsro/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hMTIx/NmIwMjAwNzM1ZTAz/NjAwYjYwOGRjMTJm/ZDYwMS5wbmc.jpg"/>
      <itunes:duration>2080</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Episode One: The Approval Playbook</p><p>Welcome to the first episode of the Bench Strength podcast, featuring Maritza McIntyre in conversation with Dr. David Dismuke.</p><p>In “The Approval Playbook,” Maritza and David dive into the world of regulatory affairs, FDA approval, gene therapy, and therapeutic development. Drawing from their career experiences in biotech, they explore how regulatory strategy has evolved, what it takes to successfully navigate the path to approval, and what the future holds for therapeutic pipelines.</p><p>Maritza shares her unique perspective on the FDA, drug development, regulatory strategy, and the evolving biopharmaceutical industry, offering insights into lessons from the past and the challenges and opportunities shaping the next generation of therapies.</p><p>Bench Strength is a podcast created by Forge Biologics. Hosted by CTO David Dismuke. Each episode features a new guest from across the gene therapy ecosystem. Everyone from scientists, clinicians, engineers, and innovators join to discuss what they're building, the lessons they've learned, and where the field is headed next. Whether you're developing your first program or preparing for commercialization, Bench Strength offers fresh perspectives from the people shaping the future of gene therapy.</p>]]>
      </itunes:summary>
      <itunes:keywords>Bench Strength podcast, gene therapy podcast, Forge Biologics podcast, David Dismuke, gene therapy, gene therapy manufacturing, cell and gene therapy, gene therapy CDMO, AAV manufacturing, viral vector manufacturing, gene therapy commercialization, gene therapy clinical development, biotech podcast, life sciences podcast, gene therapy industry leaders, gene therapy experts interview, future of gene therapy, gene therapy trends, careers in gene therapy, bench strength, Maritza McIntyre</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Welcome to the Bench</title>
      <itunes:title>Welcome to the Bench</itunes:title>
      <itunes:episodeType>trailer</itunes:episodeType>
      <guid isPermaLink="false">086edcee-b937-4fe0-8eb9-3accb0936dbb</guid>
      <link>https://share.transistor.fm/s/b65fee0d</link>
      <description>
        <![CDATA[<p>Gene therapy has reached a scale that once felt hard to imagine. The people who helped get us here have the stories, lessons, and perspective to match.<br> <br>Bench Strength, our new podcast hosted by CTO David Dismuke, Ph.D., brings those conversations from the bench to you.<br> <br>Hear from the scientists, clinicians, engineers, and leaders who helped turn what once seemed impossible into the work happening every day, and what they see from a vantage point few could have imagined when they started.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Gene therapy has reached a scale that once felt hard to imagine. The people who helped get us here have the stories, lessons, and perspective to match.<br> <br>Bench Strength, our new podcast hosted by CTO David Dismuke, Ph.D., brings those conversations from the bench to you.<br> <br>Hear from the scientists, clinicians, engineers, and leaders who helped turn what once seemed impossible into the work happening every day, and what they see from a vantage point few could have imagined when they started.</p>]]>
      </content:encoded>
      <pubDate>Tue, 11 Aug 2026 10:45:02 -0400</pubDate>
      <author>Forge Biologics</author>
      <enclosure url="https://media.transistor.fm/b65fee0d/2b1fc331.mp3" length="1038352" type="audio/mpeg"/>
      <itunes:author>Forge Biologics</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/9WagmnKGVNqi23LF_EltNoZnKh6EYYnxPr8Io_Gtcng/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84NDI1/OWJkZTY5Y2UzYmM1/ODdlOTQ5NGI0YWQx/M2JhYy5wbmc.jpg"/>
      <itunes:duration>65</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Gene therapy has reached a scale that once felt hard to imagine. The people who helped get us here have the stories, lessons, and perspective to match.<br> <br>Bench Strength, our new podcast hosted by CTO David Dismuke, Ph.D., brings those conversations from the bench to you.<br> <br>Hear from the scientists, clinicians, engineers, and leaders who helped turn what once seemed impossible into the work happening every day, and what they see from a vantage point few could have imagined when they started.</p>]]>
      </itunes:summary>
      <itunes:keywords>Bench Strength podcast, gene therapy podcast, Forge Biologics podcast, David Dismuke, gene therapy, gene therapy manufacturing, cell and gene therapy, gene therapy CDMO, AAV manufacturing, viral vector manufacturing, gene therapy commercialization, gene therapy clinical development, biotech podcast, life sciences podcast, gene therapy industry leaders, gene therapy experts interview, future of gene therapy, gene therapy trends, careers in gene therapy, bench strength </itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
  </channel>
</rss>
